ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
64,738.54
-2.63%
S&P 500
5,484.42
0.20%
Dow Jones
38,857.63
0.21%
US Dollar vs Yen
157.8325
0.08%
Brent Oil
83.795
-0.13%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Arena Pharmaceuticals Inc (ARNA)

  7. Arena Pharmaceuticals Inc (ARNA) ニュース

ARNA

Arena Pharmaceuticals (ARNA)

Arena Pharmaceuticals Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:ARNA
日付受信時刻ニュースソース見出しコード企業名
2022/03/1619 : 08Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ARNAArena Pharmaceuticals Inc
2022/03/1619 : 05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ARNAArena Pharmaceuticals Inc
2022/03/1619 : 05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ARNAArena Pharmaceuticals Inc
2022/03/1619 : 04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ARNAArena Pharmaceuticals Inc
2022/03/1206 : 25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARNAArena Pharmaceuticals Inc
2022/03/1206 : 25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARNAArena Pharmaceuticals Inc
2022/03/1206 : 25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARNAArena Pharmaceuticals Inc
2022/03/1206 : 25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARNAArena Pharmaceuticals Inc
2022/03/1206 : 23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARNAArena Pharmaceuticals Inc
2022/03/1206 : 23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARNAArena Pharmaceuticals Inc
2022/03/1206 : 23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARNAArena Pharmaceuticals Inc
2022/03/1206 : 23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARNAArena Pharmaceuticals Inc
2022/03/1206 : 13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARNAArena Pharmaceuticals Inc
2022/03/1206 : 13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARNAArena Pharmaceuticals Inc
2022/03/1206 : 13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARNAArena Pharmaceuticals Inc
2022/03/1206 : 10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARNAArena Pharmaceuticals Inc
2022/03/1206 : 08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARNAArena Pharmaceuticals Inc
2022/03/1204 : 17Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ARNAArena Pharmaceuticals Inc
2022/03/1123 : 38Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:ARNAArena Pharmaceuticals Inc
2022/03/1123 : 05Edgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NASDAQ:ARNAArena Pharmaceuticals Inc
2022/03/1123 : 02Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ARNAArena Pharmaceuticals Inc
2022/03/1123 : 02Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ARNAArena Pharmaceuticals Inc
2022/03/1123 : 02Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ARNAArena Pharmaceuticals Inc
2022/03/1123 : 02Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ARNAArena Pharmaceuticals Inc
2022/03/1122 : 59Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ARNAArena Pharmaceuticals Inc
2022/03/1122 : 59Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ARNAArena Pharmaceuticals Inc
2022/03/1122 : 59Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ARNAArena Pharmaceuticals Inc
2022/03/1122 : 59Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ARNAArena Pharmaceuticals Inc
2022/03/1122 : 59Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ARNAArena Pharmaceuticals Inc
2022/03/1122 : 59Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ARNAArena Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ARNA

最近閲覧した銘柄

LSE
ET95
Citi Fun 25
BIT
F37429
Vontobel Financial Produ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有